CAS 750621-52-4

ICCB-19

CAS : 750621-52-4

ICCB-19 is a Chinese medicinal compound that has been identified as a potent inhibitor of cancer cell growth. It induces apoptosis, or programmed cell death, in cancer cells by inhibiting specific protein kinases involved in the cell cycle. ICCB-19 has shown promising results as an anticancer agent, particularly against human tumors. This compound can be isolated from urine and has been found to be a potent inhibitor of various types of kinases, making it a promising candidate for future drug development. Its unique mechanism of action makes it an attractive option for cancer treatment.

Formule : C₁₂H₂₂ClN₃OS

Degré de pureté : Min. 95%

Masse moléculaire : 291.84 g/mol

Ref: 3D-AFB62152